Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones07-24 05:25

DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. $(INO)$ slid 3.77% to $1.02 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 2.15% to 25,137.69 and Dow Jones Industrial Average falling 0.97% to 51,711.65.

This was the stock's second consecutive day of losses.

Inovio Pharmaceuticals Inc. closed 65.76% below its 52-week high of $2.98, which the company reached on September 9th.

The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 1.42% to $259.27, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 0.77% to $25.01.

Trading volume (2.2 M) eclipsed its 50-day average volume of 1.9 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

July 23, 2026 17:25 ET (21:25 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2653977961?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-24 05:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2653977961","market":"sh","top_or_hot":-1,"title":"Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Inovio Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/INO\">$(INO)$</a> slid 3.77% to $1.02 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.15% to 25,137.69 and Dow Jones Industrial Average  falling 0.97% to 51,711.65. \n</p>\n<p>\n     This was the stock's second consecutive day of losses. \n</p>\n<p>\n     Inovio Pharmaceuticals Inc. closed 65.76% below its 52-week high of $2.98, which the company reached on September 9th. \n</p>\n<p>\n     The stock underperformed when compared to some of its competitors Thursday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> rose 1.42% to $259.27, <a href=\"https://laohu8.com/S/STAB\">Statera Biopharma</a> Inc. (STAB) remained unchanged, and Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> rose 0.77% to $25.01. \n</p>\n<p>\n     Trading volume (2.2 M) eclipsed its 50-day average volume of 1.9 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2026. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 23, 2026 17:25 ET (21:25 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-07-24 05:25</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Inovio Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/INO\">$(INO)$</a> slid 3.77% to $1.02 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.15% to 25,137.69 and Dow Jones Industrial Average  falling 0.97% to 51,711.65. \n</p>\n<p>\n     This was the stock's second consecutive day of losses. \n</p>\n<p>\n     Inovio Pharmaceuticals Inc. closed 65.76% below its 52-week high of $2.98, which the company reached on September 9th. \n</p>\n<p>\n     The stock underperformed when compared to some of its competitors Thursday, as Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> rose 1.42% to $259.27, <a href=\"https://laohu8.com/S/STAB\">Statera Biopharma</a> Inc. (STAB) remained unchanged, and Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> rose 0.77% to $25.01. \n</p>\n<p>\n     Trading volume (2.2 M) eclipsed its 50-day average volume of 1.9 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2026. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 23, 2026 17:25 ET (21:25 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DGRO","symbol_name":"iShares Core Dividend Growth ETF","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2653977961","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2653977961","pubTimestamp":1784841900,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  slid 3.77% to $1.02 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.15% to 25,137.69 and Dow Jones Industrial Average  falling 0.97% to 51,711.65.This was the stock's second consecutive day of losses.Inovio Pharmaceuticals Inc. closed 65.76% below its 52-week high of $2.98, which the company reached on September 9th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  rose 1.42% to $259.27, Statera Biopharma Inc.  remained unchanged, and Pfizer Inc.  rose 0.77% to $25.01.Trading volume  eclipsed its 50-day average volume of 1.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2026.This content was created by MarketWatc","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"DGRO":"iShares Core Dividend Growth ETF","XLI":"工业指数ETF-SPDR","DDM":"2倍做多道指ETF-ProShares","VUG":"成长股指数ETF-Vanguard MSCI","BK4568":"美国抗疫概念","DJIA":"Global X Dow 30 Covered Call ETF","YMAX":"YieldMax Universe Fund of Option Income ETF","FDN":"First Trust Dow Jones Internet I","FDVV":"Fidelity High Dividend ETF","BK4583":"猴痘概念","TOPT":"iShares Top 20 U.S. Stocks ETF","GRNY":"Fundstrat Granny Shots U.S. Large Cap ETF","DGRW":"智慧树美国优质红利成长基金","DVY":"股息指数ETF-iShares Dow Jones","INO":"伊诺维奥制药","SCHD":"Schwab US Dividend Equity ETF","UDOW":"三倍做多道指30ETF-ProShares","SDY":"股息指数ETF-SPDR S&P","DXD":"两倍做空道琼30指数ETF-ProShares","BK4139":"生物科技","VYM":"红利股ETF-Vanguard","DJX":"1/100道琼斯","DOG":"道指ETF-ProShares做空","VYMI":"Vanguard International High Dividend Yield ETF","MGK":"Vanguard Mega Cap Growth ETF","DIA":"道琼斯ETF","SDOW":"三倍做空道指30ETF-ProShares","SCHG":"Schwab U.S. Large -Cap Growth ET",".DJI":"道琼斯"},"translate_title":"与竞争对手相比，Inovio Pharmaceuticals Inc. 股票周四表现不佳","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MGK":0.6,"DGRO":0.6,"VUG":0.6,"DXD":0.6,"DIA":0.6,"DVY":0.6,"YMAX":0.6,"DJIA":0.6,".DJI":1.89,"VYMI":0.6,"TOPT":0.6,"INO":1.96,"UDOW":0.6,"SCHD":0.6,"FDVV":0.6,"DDM":0.6,"DJX":1.89,"DOG":0.6,"SDY":0.6,"SCHG":0.6,"GRNY":0.6,"VYM":0.6,"SDOW":0.6,"DGRW":0.6,"MYMmain":0.6,"XLI":0.6,"FDN":0.6},"content_text":"DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Inovio Pharmaceuticals Inc. $(INO)$ slid 3.77% to $1.02 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.15% to 25,137.69 and Dow Jones Industrial Average  falling 0.97% to 51,711.65. \n\n\n     This was the stock's second consecutive day of losses. \n\n\n     Inovio Pharmaceuticals Inc. closed 65.76% below its 52-week high of $2.98, which the company reached on September 9th. \n\n\n     The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 1.42% to $259.27, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 0.77% to $25.01. \n\n\n     Trading volume (2.2 M) eclipsed its 50-day average volume of 1.9 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2026. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 23, 2026 17:25 ET (21:25 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2653977961","isCrawlerRequest":true}